Metabolic enzyme gene variants predispose children receiving a busulfan/cyclophosphamide-based myeloablative conditioning to veno-occlusive disease

被引：0
|
作者：
Huezo-Diaz, P. V. [1 ]
Uppungunduri, C. R. S. [1 ]
Tyagi, A. K. [1 ]
Rezgui, M. A. [2 ]
Bernard, F. [1 ]
Chalandon, Y. [3 ]
Duval, M. [2 ]
Bittencourt, H. [2 ]
Krajinovic, M. [2 ]
Ansari, M. [1 ]
机构：
[1] Univ Hosp Geneva, Fac Med, Geneva, Switzerland
[2] CHU St Justine Res Ctr, Charles Bruneau Canc Ctr, Montreal, PQ, Canada
[3] Univ Hosp Geneva, Geneva, Switzerland
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S220 / S221
页数：2
相关论文
共 49 条
  • [21] Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma
    Massimo Eraldo Abate
    Anna Paioli
    Sivlia Cammelli
    Marilena Cesari
    Alessandra Longhi
    Emanuela Palmerini
    Stefano Ferrari
    Elisa Carretta
    Piero Picci
    Fabio Piscaglia
    Bone Marrow Transplantation, 2018, 53 : 591 - 599
  • [22] Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children
    Michaël Philippe
    Michael Neely
    Teresa Rushing
    Yves Bertrand
    Nathalie Bleyzac
    Sylvain Goutelle
    Bone Marrow Transplantation, 2019, 54 : 448 - 457
  • [23] Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney
    Hazar, V
    Kutluk, T
    Akyuz, C
    Varan, A
    Yaris, N
    Buyukpamukcu, M
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1998, 15 (01) : 85 - 89
  • [24] Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children
    Philippe, Michael
    Neely, Michael
    Rushing, Teresa
    Bertrand, Yves
    Bleyzac, Nathalie
    Goutelle, Sylvain
    BONE MARROW TRANSPLANTATION, 2019, 54 (03) : 448 - 457
  • [25] Impact of thiotepa-busulfan-fludarabine versus cyclophosphamide-based myeloablative conditioning regimen on outcomes after single unrelated cord blood transplantation for adults with haematological malignancies according to disease status
    Bittencourt, H.
    Ruggeri, A.
    Sanz, G.
    Nabhan, S.
    Sanz, J.
    Arcese, W.
    Sirvent, A.
    Ionescu, I.
    Gluckman, E.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S61 - S61
  • [26] Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning
    Sophia Chen
    James Dane Osborn
    Xinjian Chen
    Michael W. Boyer
    George B. McDonald
    Gerhard Carl Hildebrandt
    International Journal of Hematology, 2015, 102 : 729 - 731
  • [27] Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning
    Chen, Sophia
    Osborn, James Dane
    Chen, Xinjian
    Boyer, Michael W.
    McDonald, George B.
    Hildebrandt, Gerhard Carl
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (06) : 729 - 731
  • [28] Comparison of Post-Transplant Cyclophosphamide and Tacrolimus and Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receiving Myeloablative Fractionated Busulfan Conditioning Regimen
    Popat, Uday R.
    Saliba, Rima M.
    Mehta, Rohtesh S.
    Olson, Amanda
    Chen, Julianne
    Ganesh, Christina
    Woodworth, Glenda
    McMullin, Becky
    Alousi, Amin M.
    Anderlini, Paolo
    Alatrash, Gheath
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hosing, Chitra M.
    Im, Jin Seon
    Kebriaei, Partow
    Khouri, Issa F.
    Marin, David
    Nieto, Yago
    Oran, Betul
    Saini, Neeraj
    Srour, Samer A.
    Rezvani, Katayoun
    Qazilbash, Muzaffar H.
    Molldrem, Jeffrey J.
    Shpall, Elizabeth J.
    Andersson, Bode S.
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S125 - S125
  • [29] Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose busulfan-thiotepa regimen
    Cacchione, A.
    LeMaitre, A.
    Couanet, D. Valteau
    Benhamou, E.
    Amoroso, L.
    Simonnard, N.
    Hartmann, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S289 - S290
  • [30] Posttransplant Cyclophosphamide-Based Haploidentical Vs Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia
    Hong, Kyung Taek
    Park, Hyun Jin
    Kim, Bo Kyung
    An, Hong Yul
    Choi, Jung Yoon
    Kang, Hyoung Jin
    BLOOD, 2021, 138
12345